KIMS News Today

Krishna Institute of Medical Sciences Ltd Share Price

KIMS

CMP as on 18-Jun-24 3:54
₹ 2,040

icon 3.40 | 0.17%

Open
₹ 2,053
Turnover(lac)
₹ 3,345
Prev. Close
₹ 2,036.70
Day's Vol (shares)
₹ 163,980
Day's Vol (shares)
₹ 2,006.70         ₹ 2,065.70

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
Image not found

KIMS plans to expand 350-bed hospital in Bengaluru

All billing and revenue collection for the superspecialty hospital will be handled by KIMS, which will also bear operational costs.

  • 01 Jun, 2024 |
  • 3:07 PM
Image not found

KIMS Faces ₹306.97 Crore Income Tax Demand

Regarding the assessment year 2022–2023, the notice poses questions about a number of financial transactions

  • 18 Apr, 2024 |
  • 3:35 PM
Image not found

KIMS: Ramping-up Oncology and M&C specialty

Recommendation: Buy; Target price: ₹2350

  • 15 Feb, 2024 |
  • 2:47 PM
Image not found

Q3FY24 Review: KIMS: Broader story intact, barring the Q3 one-offs

Recommendation: Buy; Target price: ₹2350

  • 06 Feb, 2024 |
  • 1:36 PM
Image not found

Q2FY24 Review: KIMS: In-line quarter, barring minor delays in projects

Recommendation: Buy; Target Price: Rs 2140

  • 09 Nov, 2023 |
  • 11:08 AM
Image not found

Q1FY24 Review: KIMS: Resilient performance in a seasonally weak quarter

Recommendation: Buy; Target price: Rs 2150

  • 09 Aug, 2023 |
  • 10:45 AM
Image not found

KIMS: Doctor equity model will mitigate expansion risk

IIFL Securities hosted KIMS’ CEO, Dr. Abhinay Bollineni, for an NDR in Mumbai. KIMS remains focused on its expansion projects in its core markets of AP/Telangana and new markets of MH/KA.

  • 20 Jun, 2023 |
  • 10:37 AM
Image not found

Q4FY23 Review: KIMS: Robust quarter; expansion plans on track

Recommendation: Buy; Target Price: Rs 1780

  • 22 May, 2023 |
  • 12:58 PM
Image not found

Sanguine outlook for healthcare companies despite capacity additions from FY25: IIFL Securities

In their latest report, analysts at IIFL Securities compare the operating and financial performance of 8 listed hospital companies from FY17-H1FY23.

  • 28 Nov, 2022 |
  • 10:35 AM